Type 2 diabetes mellitus and postmenopausal osteoporosis: how to improve the quality of life?
- Authors: Sergeeva-Kondrachenko M.1, Strukov V.1, Poluboyarinov P.2, Petrova E.3
-
Affiliations:
- Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of Russia
- Penza State University of Architecture and Construction
- Penza State University
- Issue: Vol 30, No 11 (2019)
- Pages: 72-75
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/114120
- DOI: https://doi.org/10.29296/25877305-2019-11-17
- ID: 114120
Cite item
Open Access
Access granted
Abstract
Effective control of type 2 diabetes mellitus (T2DM) and postmenopausal osteoporosis (OP) remains an urgent problem, despite the large arsenal of drugs used in the therapy of these patients. The quality of life (QOL) in patients is one of the new criteria for assessing the quality of medical care, which has become widespread in recent years. The objective of the investigation was to assess QOL in patients with T2DM and postmenopausal OP according to the therapy of postmenopausal OP, by using the SF-36 Heath Status Survey questionnaire. A total of 84 patients with T2DM and postmenopausal OP were surveyed. The mean age of the examinees was 55.7±4.1 years. The higher QOL in patients with T2DM and postmenopausal OP was associated with the use of Osteomed Forte.
Full Text
About the authors
M. Sergeeva-Kondrachenko
Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaProfessor
V. Strukov
Penza Institute for Postgraduate Training of Physicians, Branch, Russian Medical Academy of Continuing Professional Education, Ministry of Health of RussiaProfessor
P. Poluboyarinov
Penza State University of Architecture and ConstructionCandidate of Agricultural Sciences
E. Petrova
Penza State UniversityCandidate of Medical Sciences
References
- Бирюкова Е. В. Остеопороз: точка зрения эндокринолога // Фарматека. - 2012; 1-12: 32-9
- Григорян О.Р., Андреева Е.Н. Менопаузальный синдром у женщин с нарушениями углеводного обмена. Альтернативные и дополнительные методы терапии в климактерии (обзор литературы) // Гинекология. - 2011; 3: 4-7
- Рожинская Л. Я. Остеопенический синдром при заболеваниях эндокринной системы и постменопаузальный остеопороз (патогенетические аспекты, диагностика и лечение). Дис. д-ра мед. наук. М., 2001; 318 с.
- Сергеева-Кондраченко М.Ю., Болотина Т.П. Качество жизни больных с сахарным диабетом 2 типа. Актуальные вопросы диагностики, лечения и реабилитации больных. Мат-лы XVII научно-практ. конф. с междунар. участ. Сб. статей / Пенза, 2014; с. 170-1
- Струков В., Елистратов Д., Кислов А. и др. Остеопороз в гериатрической практике // Врач. - 2018; 29 (6): 26-30. https://doi.org/10.29296/25877305-2018-06-05
- Джоунс О., Струков В., Кислов А. и др. Коморбидный остеопороз: проблемы и новые возможности терапии (ч. 2) // Врач. - 2017; 11: 25-9
- Струков В.И., Сергеева-Кондраченко М.Ю. Актуальные проблемы остеопороза / Пенза: Типография - РОСТРА, 2009; 342 с.
- Пушкарев Л.А., Аринчина Н.Г. Методика оценки качества жизни больных и инвалидов: метод. рекоменд. / Мн.: БНИИЭТИН, 2000; 16 с.
- Хетагурова А.К. Вопросы качества жизни в современной паллиативной медицине // Вопр. управлен. здравоохр. - 2003; 6 (13): 49-50
- Yaturu S., Humphrey S., Landry C. et al. Decreased bone mineral density in men with metabolic syndrome alone and with type 2 diabetes // Med. Sci. Monit. - 2009; 15 (1): CR5-9.
- Nicodemus K., Folsom A.; Iowa Women’s Health Study. Type 1 and type 2 diabetes and incident hip fractures in postmenopausal women // Diabetes Care. -2001; 24 (7): 1192-7. doi: 10.2337/diacare.24.7.1192.
- Melton L. 3rd, Leibson C., Achenbach S. et al. Fracture risk in type 2 diabetes: update of a population-based study // J. Bone Miner. Res. - 2008; 23 (8): 1334-42. doi: 10.1359/jbmr.080323.
Supplementary files
